1. Immunohistochemical screening for mismatch repair protein deficiency in paediatric high-grade gliomas — institutional experience and review of literature
   Sheena Alphones et al, 2021, Child's Nervous System CrossRef
2. Durable Near-Complete Response to Olaparib Plus Temozolomide and Radiation in a Patient With ATM-Mutated Glioblastoma and MSH6-Deficient Lynch Syndrome
   Danielle M. File et al, 2020, JCO Precision Oncology CrossRef
3. Clinically Actionable Insights into Initial and Matched Recurrent Glioblastomas to Inform Novel Treatment Approaches
   H. P. Ellis et al, 2019, Journal of Oncology CrossRef
4. Discovering mutated driver genes through a robust and sparse co-regularized matrix factorization framework with prior information from mRNA expression patterns and interaction network
   Jianing Xi et al, 2018, BMC Bioinformatics CrossRef
5. A novel infram deletion in MSH6 gene in glioma: Conversation on MSH6 mutations in brain tumors
   Zeinab Deris Zayeri et al, 2019, Journal of Cellular Physiology CrossRef
6. Frequency of mismatch repair protein deficiency and PD-L1 in high-grade gliomas in adolescents and young adults (AYA)
   Ghadeer Almuhaisen et al, 2021, Brain Tumor Pathology CrossRef
7. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma
   Vikas Patil et al, 2018, Gene CrossRef
8. DNA Damage Response Pathways in Cancer Predisposition and Metastasis
   Saima Shakil Malik et al, 2020, 'Essentials of Cancer Genomic, Computational Approaches and Precision Medicine CrossRef
9. Regulation of DNA Alkylation Damage Repair: Lessons and Therapeutic Opportunities
   Jennifer M. Soll et al, 2017, Trends in Biochemical Sciences CrossRef
10. DNA alkylation lesion repair: outcomes and implications in cancer chemotherapy
    Yihan Peng et al, 2021, Journal of Zhejiang University-SCIENCE B CrossRef
11. Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas
    Yoon Ah Cho et al, 2021, Journal of Neuro-Oncology CrossRef
12. MicroRNAs in molecular technology to address global diseases bench to bedside research
    Noorulain AKRAM et al, 2021, European Journal of Science and Technology CrossRef
13. Immune Checkpoint Inhibitors in Gliomas
    Aaron C. Tan et al, 2017, Current Oncology Reports CrossRef
14. Mechanism of formation of a toroid around DNA by the mismatch sensor protein
    Shivlee Nirwal et al, 2018, Nucleic Acids Research CrossRef
15. Drug resistance in glioblastoma and cytotoxicity of seaweed compounds, alone and in combination with anticancer drugs: A mini review
    Joana Ferreira et al, 2018, Phytomedicine CrossRef
16. MSH6 Aggravates the Hypoxic Microenvironment via Regulating HIF1A to Promote the Metastasis of Glioblastoma Multiforme
    Ying Shi et al, 2021, DNA and Cell Biology CrossRef
17. A DNA Repair and Cell-Cycle Gene Expression Signature in Primary and Recurrent Glioblastoma: Prognostic Value and Clinical Implications
    Matthieu Gobin et al, 2019, Cancer Research CrossRef
18. Hippo Pathway in Regulating Drug Resistance of Glioblastoma
    Giacomo Casati et al, 2021, International Journal of Molecular Sciences CrossRef
19. Comprehensive investigating of MMR gene in hepatocellular carcinoma with chronic hepatitis B virus infection in Han Chinese population
    Ning Ma et al, 2023, Frontiers in Oncology CrossRef
20. The pan-cancer landscape of prognostic germline variants in 10,582 patients
    Ajay Chatrath et al, 2020, Genome Medicine CrossRef
21. DNA mismatch repair system regulates the expression of PD-L1 through DNMTs in cervical cancer
    Fan Guo et al, 2024, Cancer Cell International CrossRef